O'Shaughnessy Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,809
| Closed | -$214K | – | 1428 |
|
|
2022
Q2 | $214K | Sell |
4,809
-2,734
| -36% | -$122K | ﹤0.01% | 1007 |
|
|
2022
Q1 | $373K | Sell |
7,543
-38
| -0.5% | -$1.88K | 0.01% | 820 |
|
|
2021
Q4 | $386K | Sell |
7,581
-210
| -3% | -$10.7K | 0.01% | 775 |
|
|
2021
Q3 | $435K | Buy |
7,791
+1,509
| +24% | +$84.3K | 0.01% | 704 |
|
|
2021
Q2 | $269K | Buy |
6,282
+5,478
| +681% | +$235K | 0.01% | 894 |
|
|
2021
Q1 | $34K | Buy |
+804
| New | +$34K | ﹤0.01% | 1521 |
|
|
2020
Q4 | – | Sell |
-9,119
| Closed | -$388K | – | 2257 |
|
|
2020
Q3 | $388K | Sell |
9,119
-11
| -0.1% | -$468 | 0.01% | 508 |
|
|
2020
Q2 | $439K | Buy |
9,130
+11
| +0.1% | +$529 | 0.01% | 430 |
|
|
2020
Q1 | $421K | Sell |
9,119
-176
| -2% | -$8.13K | 0.01% | 317 |
|
|
2019
Q4 | $557K | Buy |
+9,295
| New | +$557K | 0.01% | 375 |
|
|
2019
Q1 | – | Sell |
-1,264
| Closed | -$51K | – | 1026 |
|
|
2018
Q4 | $51K | Sell |
1,264
-3,412
| -73% | -$138K | ﹤0.01% | 708 |
|
|
2018
Q3 | $324K | Buy |
4,676
+192
| +4% | +$13.3K | 0.01% | 451 |
|
|
2018
Q2 | $339K | Sell |
4,484
-87
| -2% | -$6.58K | 0.01% | 410 |
|
|
2018
Q1 | $241K | Buy |
4,571
+4,555
| +28,469% | +$240K | 0.01% | 481 |
|
|
2017
Q4 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 899 |
|